Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France
Conditions: Primary Immunodeficiency; Common Variable Immunodeficiency; Igg Subclass Deficiency; Selective IgM Deficiency Interventions: Other: Blood test; Other: chest CT scan Sponsors: CHU de Reims Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.
Conditions: Cytopenia Interventions: Other: Identification of specific markers Sponsors: Meyer Children ' s Hospital IRCCS Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill
Conditions: Primary Immunodeficiency Diseases (PID) Interventions: Other: No Intervention Sponsors: Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety and Pharmacokinetics of Boya IVIG
Conditions: Primary Immunodeficiency Disease Interventions: Biological: Boya IVIG Sponsors: Azidus Brasil; Boya Bio Pharmaceutical Group Co Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials

Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency
Conditions: Primary Immunodeficiency Interventions: Other: Inspiratory muscle training; Other: Upper extremity aerobic exercise training; Other: Lower extremity aerobic exercise training; Other: Resistant exercise training; Other: Thoracic expansion exercises Sponsors: Gazi University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials

Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG
Conditions: Primary Immunodeficiency Disease Interventions: Biological: IVIG Sponsors: Azidus Brasil; Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
Conditions: Primary Immunodeficiency Diseases (PID) Interventions: Biological: TAK-881 Sponsors: Takeda; Takeda Development Center Americas, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials

Exercise Capacity, Physical Activity Level and Quality of Life in Children With Primary Immunodeficiency
Condition:   Primary Immunodeficiency Diseases Intervention:   Sponsor:   Gazi University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies
Condition:   Primary Immunodeficiency Diseases (PID) Intervention:   Drug: Cutaquig Sponsor:   Federal Research Institute of Pediatric Hematology, Oncology and Immunology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials